PNH Condition Explained

The question asks to identify a condition characterized by a specific triad: haemolysis, pancytopenia, and venous thrombosis.

Paroxysmal Nocturnal Haemoglobinuria Triad

Paroxysmal nocturnal haemoglobinuria (PNH) is a rare acquired disorder that characteristically presents with this triad:

• Haemolysis: Red blood cells (RBCs) are abnormally sensitive to complement-mediated lysis due to a deficiency in glycosylphosphatidylinositol (GPI)-anchored proteins, like CD55 and CD59. This leads to intravascular haemolysis.
• Pancytopenia: Bone marrow stem cells are also affected by the PNH clone (mutation in the PIGA gene). This leads to impaired production of RBCs, white blood cells (WBCs), and platelets, resulting in pancytopenia.
• Venous Thrombosis: PNH significantly increases the risk of thrombosis, particularly affecting unusual sites like hepatic, portal, mesenteric, and cerebral veins. This is thought to be related to the lack of GPI-linked complement regulatory proteins on endothelial cells and potentially platelet activation.

Other Options Analysis

The other options do not typically present with all three features characteristically:

• Glucose-6-phosphate dehydrogenase deficiency: Primarily causes episodic haemolysis, especially under oxidative stress. It does not typically cause pancytopenia or venous thrombosis.
• Hereditary spherocytosis: Causes chronic haemolysis and anaemia, but usually not pancytopenia or a marked predisposition to venous thrombosis.
• Haemolytic uremic syndrome: Involves haemolysis and thrombocytopenia (low platelets), along with kidney failure. It does not typically cause pancytopenia (low WBCs and RBCs) or systemic venous thrombosis; its thrombosis is usually microvascular.

Therefore, Paroxysmal nocturnal haemoglobinuria is the condition that characteristically presents with the triad of haemolysis, pancytopenia, and venous thrombosis.